Immunization Resources & Vaccine Preventable Diseases
IPAC Canada offers these links for additional resources for infection control professionals.
Links presented here do not imply endorsement by IPAC Canada.
Table of Contents
- NACI Resources
- CDC -ACIP Resources
- Immunize Canada
- PHAC
- Canadian Paediatric Society
- Provincial Resources
- Other Resources
NACI Resources
- COVID-19
- Immunization Schedules
- Haemophilus vaccine
- Hepatitis (A&B)
- Herpes zoster vaccine
- Influenza vaccine
- Measles vaccine
- Meningococcal vaccine
- Mumps vaccine
- Papillomavirus vaccine
- Pneumococcal vaccine
- Polio vaccine
- Rabies vaccine
- Rotavirus vaccine
- RSV
- Rubella vaccine
- Smallpox vaccine
- Varicella vaccine
COVID-19 Vaccine
- NACI Statement: Interim guidance on booster COVID-19 vaccine doses in Canada
- NACI: Rapid Response Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccine
- NACI: Guidance on booster COVID-19 vaccine doses in Canada
- NACI: Summary of the updated vaccine statement -MRNA COVID-19 Vaccines and Myocarditis
- NACI Statement: Interim guidance on booster COVID-19 vaccine doses in Canada
- NACI: Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply
- NACI: Summary of Extended Dose Intervals Statement of April 7, 2021
- Summary of the NACI Statement -Recommendation on the use of the PfizerBioNTech COVID-19 Vaccine in children 5-11 years of age
- NACI Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age
- NACI: Rapid Response: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age
- NACI: Summary of the NACI rapid response of January 28, 2022
- NACI Statement: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz
- Summary of the NACI statement of March 11, 2022
- NACI Statement: Initial guidance on a second booster dose of COVID-19 vaccines in Canada
- NACI Statement: Updated guidance on a first booster dose of COVID-19 vaccines in Canada
- NACI Summary: Updated guidance on a first booster dose of COVID-19 vaccines in Canada
- NACI Statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age
- Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age
- Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
- Summary of NACI of June 29, 2022 -Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
- NACI Statement: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding
- NACI Summary: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding
- NACI Statement: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age
- NACI Summary: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age
- Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults
- Summary of NACI updates: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults
- Summary of NACI statement : Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
- NACI Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
- NACI Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19
- Summary of NACI statement: NACI Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19
- NACI Guidance on the use of COVID-19 vaccines in the fall of 2023
- Summary of NACI statement: Guidance on the use of COVID-19 vaccines in the fall of 2023
Influenza Vaccine
- National Advisory Committee on Immunization (NACI): Statements and publications
- Influenza surveillance through citizen science
- National Advisory Committee on Immunization (NACI): Statements and publications
- NACI Statement on seasonal influenza vaccine for 2023-2024
- Summary of the National Advisory Committee on Immunization statement on seasonal influenza vaccine for 2023-2024
Measles Vaccine
- Canadian Immunization Guide: Measles vaccines
- Summary of NACI statement of February 13, 2025: Updated recommendations on measles post-exposure prophylaxis
- Prevention and Control of Occupational Infections in Health Care (2002, PHAC)
- CCDR - Updated NACI recommendations for measles post-exposure prophylaxis
- Update on measles-mumps-rubella-varicella vaccine and febrile seizures
- National Advisory Committee on Immunization recommendations for measles post-exposure prophylaxis
- Update on measles-mumps-rubella-varicella vaccine and febrile seizures (2016)
- Statement from the Chief Public Health Officer of Canada on Measles and the Risk to Canadians
- Measles: What you should know (factsheet) (PHAC)
- Measles: For health professionals (PHAC)
- Measles and Rubella Weekly Monitoring Reports (PHAC)
- Immunize Canada Resources: Poster, Myth busing, Fact Sheet, Pocket Guide for Immunizers (en français)
- Measles (PHO)
- Measles: Information for Health Care Providers (PHO)
- Interim IPAC Recommendations and Use of PPE for Care of Individuals with Suspect or Confirmed Measles (PHO)
- Measles (BC CDC)
- Measles (Gove)rnment of Quebec)
- Measles outbreak (Government of Quebec)
- Measles (Saskatchewan
RSV Vaccine
- NACI Statement on the prevention of respiratory syncytial virus (RSV) disease in infants
- NACI Summary: Statement on the prevention of respiratory syncytial virus (RSV) disease in infants
- Statement on the prevention of respiratory syncytial virus (RSV) disease in infants: Supplementary systematic review of economic evidence
CDC-ACIP Resources
- General Recommendations on Immunization
- Immunization of HCWs
- Diphtheria, Pertussis, Tetanus (DTaP)
- Hepatitis A
- Hepatitis B
- Herpes Zoster
- Influenza
- Meningococcal Disease
- Orthopoxviruses (Smallpox & Mpox)
- Pneumococcal Disease
- Rabies
- Typhoid
- Varicella (Chickenpox)
- Yellow Fever
Immunize Canada
- National Immunization Awareness Week
- Immunization Promotional Material
- Resources for health care providers
- Current Influenza Campaign Materials
- Herpes zoster pocket guide for immunizers
- Pneumococcal immunization pocket guides for immunizers
- "Immunization information on the internet: can you trust what you read?"
Public Health Agency of Canada
- Canadian Immunization Guide
- Immunization & Vaccines
- Immunization Competencies for Health Professionals
- Vaccine safety: Resources for health professionals on surveillance, reporting and regulation
Canadian Pediatric Society
- Vaccine recommendations for children and youth for the 2023/2024 influenza season
- Update on invasive meningococcal vaccination for Canadian children and youth
- Education Program for Immunization Competencies (EPIC)
- Programme de formation sur les compétences en matière d’immunisation (EPIC)
Provincial Resources
- British Columbia: Immunize BC
- Alberta: Immunization
- Saskatchewan: Immunization Services and Information
- Manitoba: Diseases and Immunization (Vaccination) & Cold Chain Resources
- Ontario: Immunization Information,
- Quebec: Quebec Immunization Program
- New Brunswick: Immunization
- Nova Scotia: Immunization
- Prince Edward Island: Immunization
- Newfoundland/Labrador: Immunization
- Northwest Territories: Immunization and Vaccines
- Yukon: Immunization and Vaccines
- Nunavut: Nunavut Recommended Childhood Immunization Schedule
Other Resources
- Uniting Diverse Groups to Improve Adult Influenza Vaccination in Canada / Press release / Media Toolkit -IFA
- Vaccines and Immunizations - CDC
- Immunization Information - WHO
- Not Just for Kids: How to Improve Adult Vaccination Uptake in Canada -CD Howe Institute / Pas seulement pour les enfants : comment améliorer la surveillance et la couverture vaccinale chez les adultes au Canada -Institue (CD Howe)
- Free, bilingual mobile app created to help Canadians and their families keep track of their immunizations (CANImmunize)
